Adult native septic arthritis: A review of 10 years of experience and lessons for empirical antibiotic therapy

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 5, 2011, Pages 1168-1173

  Clerc, Olivier ^a   Prod'hom, Guy ^a   Greub, Gilbert ^a   Zanetti, Giorgio ^a   Senn, Laurence ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Antibiotic stewardship; Osteoarticular infections; Practice guidelines

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFUROXIME; FLUCLOXACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL ARTHRITIS; BACTERIUM CULTURE; FEMALE; HUMAN; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; RETROSPECTIVE STUDY; REVIEW; STREPTOCOCCUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ARTHRITIS, INFECTIOUS; BACTERIA; BACTERIAL INFECTIONS; HUMANS; MIDDLE AGED; RETROSPECTIVE STUDIES; SWITZERLAND; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79954603180     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr047     Document Type: Review

References (34)

1. Mathews CJ, Weston VC, Jones A et al. Bacterial septic arthritis in adults. Lancet 2010; 375: 846-55.
2. Shirtliff ME, Mader JT. Acute septic arthritis. Clin Microbiol Rev 2002; 15: 527-44.
3. Pioro MH, Mandell BF. Septic arthritis. Rheum Dis Clin North Am 1997; 23: 239-58.
4. Ryan MJ, Kavanagh R, Wall PG et al. Bacterial joint infections in England and Wales: analyses of bacterial isolates over a four year period. British J Rheum 1997; 36: 370-3.
5. Kaandorp CJE, Dinant HJ, Van de Laar MA et al. Incidence and sources of native and prosthetic joint infection: a community based prospective survey. Ann Rheum Dis 1997; 56: 470-5.
6. Favero M, Schavon F, Riato L et al. Rheumatoid arthritis is the major risk factor for septic arthritis in rheumatological settings. Autoimmun Rev 2008; 8: 59-61.
7. Kaandorp CJE, Krijnen P, Bernelot Moens HJ et al. The outcome of bacterial arthritis. Arthritis Rheum 1997; 40: 884-92.
8. Gupta MN, Sturrock RD, Field M. A prospective 2-year study of 75 patients with adult-onset septic arthritis. Rheumatology 2001; 40: 24-30.
9. Weston VC, Jones AC, Bradbury N et al. Clinical features and outcome of septic arthritis in a single UK Health District 1982-1991. Ann Rheum Dis 1999; 58: 214-9.
10. Cooper C, Cawley MID. Bacterial arthritis in an English health district: a year review. Ann Rheum Dis 1986; 45: 458-63.
11. Margaretten ME, Kohlwes J, Moore D et al. Does this adult patient have septic arthritis?. JAMA 2007; 297: 1478-88.
12. Coakley G, Mathews C, Field M et al. BSR & BHPR, BOA, RCGP and BSAC guidelines for management of the hot swollen joint in adults. Rheumatology 2006; 45: 1039-41.
13. Stengel D, Bauwens K, Sehouli J et al. Systematic review and meta-analysis of antibiotic therapy for bone and joint infections. Lancet Infect Dis 2001; 1: 175-88.
14. Weston V, Coakley G. Guideline for the management of the hot swollen joint in adults with a particular focus on septic arthritis. J Antimicrob Chemother 2006; 58: 492-3.
15. Dellit TH, Owens RC, McGowan JE et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007; 44: 159-77.
16. Morgan DS, Fisher D, Merianos A et al. An 18 year clinical review of septic arthritis from tropical Australia. Epidemiol Infect 1996; 117: 423-8.
17. Eder L, Zisman D, Rozenbaum M et al. Clinical features and etiology of septic arthritis in northern Israel. Rheumatology 2005; 44: 1559-63.
18. Dubost JJ, Soubrier M, De Champs C et al. No changes in the distribution of organisms responsible for septic arthritis over a 20 year period. Ann Rheum Dis 2002; 61: 267-9.
19. Rossolini GM, Mantengoli E. Antimicrobial resistance in Europe and its potential impact on empirical therapy. Clin Microbiol Infect 2008; 14 Suppl 6: 2-8.
20. Harrington JT. Mycobacterial and fungal arthritis. Curr Opin Rheumatol 1998; 10: 335-8.
21. Wheat LJ, Allen SD, Henry M et al. Diabetic foot infections: bacteriologic analysis. Arch Intern Med 1986; 146: 1935-40.
22. Lipsky BA, Berendt AR, Gunner Deery H et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2004; 39: 885-910.
23. Rao N, Lipsky BA. Optimizing antimicrobial therapy in diabetic foot infections. Drugs 2007; 67: 195-214.
24. Chambers HF, DeLeo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol 2009; 7: 629-41.
25. Gupta MN, Sturrock RD, Field M. Prospective comparative study of patients with culture proven and high suspicion of adult onset septic arthritis. Ann Rheum Dis 2003; 62: 327-31.
26. Ross JJ, Davidson L. Methicillin-resistant Staphylococcus aureus septic arthritis: an emerging clinical syndrome. Rheumatology 2005; 44: 1197-8.
27. Al-Nammari SS, Bobak P, Venkatesh R. Methicillin resistant Staphylococcus aureus versus methicillin sensitive Staphylococcus aureus adult haematogenous septic arthritis. Arch Orthop Trauma Surg 2007; 127: 537-42.
28. Huang SS, Platt R. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis 2003; 36: 281-5.
29. Datta R, Huang SS. Risk of infection and death due to methicillinresistant Staphylococcus aureus in long term carriers. Clin Infect Dis 2008; 47: 176-81.
30. Brancos MA, Peris P, Miro JM et al. Septic arthritis in heroin addicts. Semin Arthritis Rheum 1991; 21: 81-7.
31. Chandrasekar PH, Narula AP. Bone and joint infection in intravenous drug abusers. Rev Infect Dis 1986; 8: 904-11.
32. Baum C, Hsu JP, Nelson RC. The impact of the addition of naloxone on the use and abuse of pentazocine. Public Health Rep 1987; 102: 426-9.
33. Ross JJ, Shamsuddin H. Sternoclavicular septic arthritis, review of 180 cases. Medicine 2004; 83: 139-48.
34. Huang H, Cohen SH, Monchaud C et al. Injecting drug use and community-associated methicillin-resistant Staphylococcus aureus infection. Diagn Microbiol Infect Dis 2008; 60: 347-50.